Global Innovative Platforms (GIPL) Liabilities and Shareholders Equity (2021 - 2026)
Global Innovative Platforms (GIPL) posted Liabilities and Shareholders Equity of $591958.0 for Q1 2026, up 163.15% sequentially from $224951.0 in Q4 2025, and up 254.61% YoY from $166932.0 in Q1 2025.
Global Innovative Platforms (GIPL) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Global Innovative Platforms has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $591958.0 in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 254.61% year-over-year to $591958.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 276.39% YoY) and the FY2025 annual result came in at $199275.0, up 1328400.0% from the prior year.
- Liabilities and Shareholders Equity advanced to $591958.0 in Q1 2026 per GIPL's latest filing, from $224951.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $591958.0 in Q1 2026 and troughed at $15.0 in Q3 2024.
- A 5-year average of $98211.6 and a median of $10146.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity sank 99.13% in 2023, then soared 1328400.0% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $64403.0 in 2022, then slumped by 97.38% to $1685.0 in 2023, then jumped by 8710.62% to $148459.0 in 2024, then jumped by 51.52% to $224951.0 in 2025, then surged by 163.15% to $591958.0 in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $591958.0, $224951.0, and $199275.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 261.48 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.80 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 514.10 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.99 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.35 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.73 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 314.37 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 374.60 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.80 Mn |
| 10 | Global Innovative Platforms | 22.39 Mn | 22.14 Mn | - | 539,261.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591,958.00 |
| Dec 31, 2025 | 224,951.00 |
| Sep 30, 2025 | 199,275.00 |
| Jun 30, 2025 | 209,160.00 |
| Mar 31, 2025 | 166,932.00 |
| Dec 31, 2024 | 148,459.00 |
| Sep 30, 2024 | 15.00 |
| Jun 30, 2024 | 10,146.00 |
| Mar 31, 2024 | 596.00 |
| Dec 31, 2023 | 1,685.00 |
| Sep 30, 2023 | 415.00 |
| Jun 30, 2023 | 361.00 |
| Mar 31, 2023 | 2,961.00 |
| Dec 31, 2022 | 64,403.00 |
| Sep 30, 2022 | 47,757.00 |
| Jun 30, 2022 | 262.00 |
| Mar 31, 2022 | 262.00 |
| Dec 31, 2021 | 262.00 |
| Sep 30, 2021 | 262.00 |
| Jun 30, 2021 | 18,500.00 |